Category Archives: Pradaxa

Featured Stories

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement

Xarelto Plaintiffs Hope for Similar Pradaxa Settlement

The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , , , , , |

Pradaxa Linked to Brain Bleeds

Pradaxa Linked to Brain Bleeds

Researchers report that they have found a possible link between the anticoagulant drug Pradaxa and intracerebral hemorrhage (brain bleeding). When a blood vessel wall or vein is damaged, the vessel can leak blood into tissues, causing a hematoma, a swelling … Continue reading

Posted in Health Concerns, Pharmaceuticals, Pradaxa | Tagged , , , , , , , , , , , , , , , , |

Pradaxa Settlement Does Not Bar New Lawsuits

Despite a 2014 mass settlement, patients who have suffered bleeding injuries after taking Pradaxa may still qualify to bring a Pradaxa lawsuit. Pradaxa is one of the newer class of blood-thinning medication prescribed to help prevent blood clots and stroke … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Pradaxa |

Anticoagulant Xarelto Lawsuit Cases Keep Drawing Attention

Lawsuits seeking damages from the makers of Xarelto, Bayer AG and Janssen Pharmaceuticals (a subdivision of Johnson & Johnson), have surpassed 3,000 in number with many plaintiffs alleging they suffered similar harm resulting from taking the drug, reports the Digital … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

Blood Thinner Xarelto Lawsuit Continues to Draw Attention

Regarding the multitude of cases brought against the manufacturers of the anticoagulant drug, Xarelto, Bayer AG, Janssen Pharmaceuticals, a division of Johnson & Johnson, have surpassed 3,000 cases and many allege similar harm as a result of using the drug, … Continue reading

Posted in Health Concerns, Pharmaceuticals, Pradaxa |

Xarelto Studies Question Drugs Benefits and Risks and Reveal Eye Bleeding in Some Cases

A number of study results are prompting questions over Xarelto (rivaroxaban) and other new-generation anticoagulant drugs (blood thinners). Bayer Healthcare and Janssen Pharmaceuticals, a division of the Johnson & Johnson Corporation, manufacture Xarelto. Xarelto received U.S. Food and Drug Administration … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Motion to Consolidate Xarelto Bleeding Side Effects Cases in Multidistrict Litigation

Plaintiffs who allege they were injured by the blood thinner Xarelto have filed a motion to have their cases consolidated as part of a multidistrict litigation (MDL). At least 21 actions pending in 10 judicial districts make similar allegations against … Continue reading

Posted in Defective Products, Pharmaceuticals, Pradaxa |

Pradaxa Maker Reaches $650 Million Settlement in State and Federal Litigation

Drug maker Boehringer Ingelheim announced today that it had reached a $650 million settlement of state and federal cases involving the blood thinner Pradaxa (dabigatran). Though the company says it “stands resolutely behind” Pradaxa and believes the claims in the … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

FDA Study: Pradaxa Has Higher Risk for Gastrointestinal Bleeding than Warfarin

A study recently completed by the Food and Drug Administration (FDA) found an increased risk of major gastrointestinal bleeding with the blood thinner Pradaxa (dabigatran) compared to warfarin. Pradaxa and warfarin (Coumadin) are prescribed to reduce the risk of stroke … Continue reading

Posted in Health Concerns, Pharmaceuticals, Pradaxa |

Xarelto Caused Internal Bleeding, Lawsuit Claims

xarelto-bleeding-lawsuits

A Kentucky woman has filed suit against Johnson & Johnson and Bayer AG in Pennsylvania court, alleging that she suffered severe internal bleeding from the use of the blood-thinner Xarelto (rivaroxaban). Virginia Stuntebeck’s lawsuit says the drug should not be … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.